Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Susan, Moran"'
Autor:
Daniel P. Petrylak, Cindy Xu, Corina Andresen, Ulka N. Vaishampayan, Jessica Rearden, Howard A. Burris, Jean H. Hoffman-Censits, Ugo De Giorgi, Sumanta K. Pal, Sumati Gupta, Jonathan E. Rosenberg, Dean F. Bajorin, Yung Lyou, Ai Li, Siamak Daneshmand, David I. Quinn, Petros Grivas, Susan Moran, Matthew D. Galsky
Publikováno v:
Clinical Genitourinary Cancer. 20:35-42
Introduction To describe the efficacy of infigratinib, a potent, selective fibroblast growth factor receptor (FGFR) 1-3 tyrosine kinase inhibitor, across lines of therapy (LOT) in patients with metastatic urothelial cancer (mUC). Patients and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2428233032a6d684f85f15c3e753f32f
https://doi.org/10.1016/j.clgc.2021.10.004
https://doi.org/10.1016/j.clgc.2021.10.004
Autor:
Patrick Roth, Susan Moran, Ge Wei, Francesca Avogadri, Cindy Xu, Steven Rowsey, Harris S. Soifer, Pierre Giglio, Cristóbal Belda-Iniesta, Morris D. Groves, Paul M.J. Clement, Nicholas A. Butowski, Patrick Y. Wen, Filip Y.F. De Vos, Jeffrey J. Raizer, Vinay K. Puduvalli, Miguel J. Gil-Gil, Timothy F. Cloughesy, Juan Manuel Sepúlveda-Sánchez, Andrew B. Lassman
Supplementary Table from Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e62bc045083f295b5505a4d2ceb22bf
https://doi.org/10.1158/1078-0432.22483670.v1
https://doi.org/10.1158/1078-0432.22483670.v1
Autor:
Patrick Roth, Susan Moran, Ge Wei, Francesca Avogadri, Cindy Xu, Steven Rowsey, Harris S. Soifer, Pierre Giglio, Cristóbal Belda-Iniesta, Morris D. Groves, Paul M.J. Clement, Nicholas A. Butowski, Patrick Y. Wen, Filip Y.F. De Vos, Jeffrey J. Raizer, Vinay K. Puduvalli, Miguel J. Gil-Gil, Timothy F. Cloughesy, Juan Manuel Sepúlveda-Sánchez, Andrew B. Lassman
Purpose:FGFR genomic alterations (amplification, mutations, and/or fusions) occur in ∼8% of gliomas, particularly FGFR1 and FGFR3. We conducted a multicenter open-label, single-arm, phase II study of a selective FGFR1–3 inhibitor, infigratinib (B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4433b4500bfad782b57ee3a0f26473dc
https://doi.org/10.1158/1078-0432.c.6531203
https://doi.org/10.1158/1078-0432.c.6531203
Autor:
Patrick Roth, Susan Moran, Ge Wei, Francesca Avogadri, Cindy Xu, Steven Rowsey, Harris S. Soifer, Pierre Giglio, Cristóbal Belda-Iniesta, Morris D. Groves, Paul M.J. Clement, Nicholas A. Butowski, Patrick Y. Wen, Filip Y.F. De Vos, Jeffrey J. Raizer, Vinay K. Puduvalli, Miguel J. Gil-Gil, Timothy F. Cloughesy, Juan Manuel Sepúlveda-Sánchez, Andrew B. Lassman
Supplementary Figure from Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1563a5aa4a79c34480a823bb1d174a04
https://doi.org/10.1158/1078-0432.22483673
https://doi.org/10.1158/1078-0432.22483673
Autor:
Daniel J. George, H. Mark Lin, Shih-Yuan Lee, Susan Moran, Justine Y. Bruce, Charles J. Ryan, Joshi J. Alumkal, Hans J. Hammers, M. Dror Michaelson, Paul G. Corn, Maha Hussain
Supplementary Table S1- Number of patients with 1-4 and {greater than or equal to}5 CTCs per 7.5mL of whole blood at baseline, and at 3, 6 and 12 months. Supplementary Table S2- Biochemical markers of bone turnover and bone mineral density (BMD).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49c89d8221c1c8f8fc419178bbed2bff
https://doi.org/10.1158/1078-0432.22454825.v1
https://doi.org/10.1158/1078-0432.22454825.v1
Autor:
Thomas Hope, Samuel Mehr, Michael Morris, Daneng Li, MD Daniel Halperin, Jonathan Strosberg, Heloisa Soares, Heather Jacene, Marianne Pavel, Kunz Pamela L., Denis Ferreira, Joanne Li, Kimberly Ma, Jessica Rearden, Susan Moran, Simron Singh
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3f2748b52e8f2947b53edb2844ccfca
https://doi.org/10.1530/endoabs.89.t6
https://doi.org/10.1530/endoabs.89.t6
Autor:
Zhang, Xin, Susan Moran, M., Zhao, Xiang, Liu, Suhong, Zhou, Tao, Ponce-Campos, Guillermo E., Liu, Feng
Publikováno v:
In Remote Sensing of Environment July 2014 150:188-197
Autor:
Guangzhou Han, Eunmi Hwang, Fanching Lin, Renee Clift, Daniel Kim, Eric Bischoff, Susan Moran, Gary Li
Publikováno v:
Cancer Research. 83:5042-5042
Introduction: Overexpression of somatostatin receptors (SSTRs), particularly SSTR2, is found in gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and subsets of other solid tumors such as small-cell lung cancer (SCLC). β-emitting radiopharmac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d29042b9dd7681b5d9808bc338741efe
https://doi.org/10.1158/1538-7445.am2023-5042
https://doi.org/10.1158/1538-7445.am2023-5042
Autor:
Andrew B. Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy F. Cloughesy, Miguel J. Gil-Gil, Vinay K. Puduvalli, Jeffrey J. Raizer, Filip Y.F. De Vos, Patrick Y. Wen, Nicholas A. Butowski, Paul M.J. Clement, Morris D. Groves, Cristóbal Belda-Iniesta, Pierre Giglio, Harris S. Soifer, Steven Rowsey, Cindy Xu, Francesca Avogadri, Ge Wei, Susan Moran, Patrick Roth
Publikováno v:
Clin Cancer Res
Purpose: FGFR genomic alterations (amplification, mutations, and/or fusions) occur in ∼8% of gliomas, particularly FGFR1 and FGFR3. We conducted a multicenter open-label, single-arm, phase II study of a selective FGFR1–3 inhibitor, infigratinib (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1992e8a27b1403d69013c5615f19e6fc
https://www.zora.uzh.ch/id/eprint/230044/
https://www.zora.uzh.ch/id/eprint/230044/
Autor:
Mallory L. Barnes, M. Susan Moran, Russell L. Scott, Thomas E. Kolb, Guillermo E. Ponce‐Campos, David J. P. Moore, Morgan A. Ross, Bhaskar Mitra, Sabina Dore
Publikováno v:
Ecosphere, Vol 7, Iss 5, Pp n/a-n/a (2016)
Abstract In the southwest United States, the current prolonged warm drought is similar to the predicted future climate change scenarios for the region. This study aimed to determine patterns in vegetation response to the early 21st century drought ac
Externí odkaz:
https://doaj.org/article/657dfabb4e29415fb2958f45b0316d3a